VAR-102

N/A

Report date: 2024/05/09 13:41:25
NME

Base Information

Drug NameVAR-102
Drug Alias NameVAR-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitors
TargetsProtein kinase C
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVarian Biosynergy Inc
China Registration ClassN/A

Develop Information

Active CompaniesVarian Biopharmaceuticals IncWindtree Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A